FDA
FDA biologics chief Vinay Prasad to leave agency at end of April
Ti AI ṣe iroyin Àwòrán tí AI ṣe Ti ṣayẹwo fun ododo
Dr. Vinay Prasad, who leads the FDA division that oversees vaccines and other biological products, will leave the agency at the end of April, FDA Commissioner Marty Makary told staff in an email. It will be Prasad’s second departure in less than a year after a brief exit last summer amid clashes over high-profile drug and vaccine reviews.
Inovio Pharmaceuticals held its first-quarter 2026 earnings call on May 13 to discuss financial results for the period ended March 31 and provide updates on its DNA medicines platform.
Ti AI ṣe iroyin
Syntara Limited held a shareholder webinar on April 29 to discuss FDA feedback on its proposed Phase IIb trial for amsulostat in myelofibrosis, along with a capital raise and quarterly report. CEO Gary Phillips highlighted the agreed path forward with regulators. The company lodged its Appendix 4C quarterly with the ASX.
The U.S. Senate has confirmed Robert Califf to lead the Food and Drug Administration amid ongoing public health challenges. Califf, a cardiologist with prior FDA experience, was approved in a bipartisan vote. This move aims to stabilize the agency during debates over drug approvals and regulations.
Ti AI ṣe iroyin
The U.S. Supreme Court unanimously ruled on June 13, 2024, that the FDA's approval of the abortion pill mifepristone is valid and remains in effect. The decision dismissed challenges from anti-abortion groups, affirming the agency's regulatory authority. This ruling ensures continued access to medication abortion, which accounts for more than half of U.S. abortions.
The FDA approved a new drug for treating autoimmune neuropathies on September 9, 2025, accompanied by discoveries of new autoantibodies and effective complement inhibitors. This development ends 30 years of limited treatment progress in the field.
Ti AI ṣe iroyin Ti ṣayẹwo fun ododo
The US Food and Drug Administration granted clearance to Apple's new hypertension detection feature for the Apple Watch on September 11, 2025. The feature, announced at Apple's early September product launch, will be available in 150 countries starting next week.
FDA approves Travere Therapeutics' FILSPARI for FSGS
January 01, 2026 08:26US FDA approves first oral pill for thalassaemia anaemia
November 20, 2025 04:09Paradromics receives FDA approval for brain implant trial
November 12, 2025 22:22Poll, high‑profile cases fuel bipartisan push to revisit mail‑order abortion pill rules
November 11, 2025 09:36FDA removes black box warning from menopause hormone therapy
September 30, 2025 00:32FDA issues final rule on clinical trials diversity
September 26, 2025 00:23Coalition Opposes FDA's Proposed Ban on 7-OH Substance
September 22, 2025 00:09FDA Approves Injectable Form of Merck's Keytruda
September 20, 2025 00:15FDA Grants Accelerated Approval for First Barth Syndrome Treatment
September 15, 2025 00:23FDA Approves New Hypertension Detection Device